首页> 外文期刊>Asian Journal of Medical Sciences >Usage of diuretics among diabetic-hypertensive patients
【24h】

Usage of diuretics among diabetic-hypertensive patients

机译:糖尿病高血压患者中利尿剂的使用

获取原文
           

摘要

Background: Hypertension is more common in diabetics than in non-diabetic patients. An aggressive approach to the diagnosis and treatment of hypertension in patients with diabetes is required in order to substantially reduce the incidence of both macro-vascular and micro-vascular complications. The role of diuretics in the treatment of hypertension as first line or second line drugs is a provoking debate, hence we studied the usage of diuretics and their effects on BP and glycemic control among diabetic-hypertensive patients. Methods: This cross sectional study was carried out for a period of six months in a tertiary care teaching hospital. Patients’ details such as age, gender, height, weight, comorbid diseases, blood pressure, eGFR along with duration of diabetes and hypertension and drugs prescribed for hypertension were noted. Data were analyzed using descriptive statistics. Results: A total of 336 diabetic-hypertensiveswith a mean age of 64.55±9.51 years were included. Fortyfive patients were on diuretics,two (4.4%) of whom were on diuretic monotherapy, 16 (35.6%) on two drug combinations (Diuretic + ACEI or ARB), 21 (46.7%) on three drug combinations (diuretics + ARB & BBs or diuretic + ACEI & BB or diuretic + ARB &CCB) and six (13.3%) were on four drug combinations (diuretics + ARB, CCB & BB). Among the patients on diuretic combination therapy BP was well controlled in 23 (51%) patients and the glycemic control was comparable to those not on diuretics. Conclusion: In the present study the usage of diuretics was consistent with the guidelines. About 13% of diabetic-hypertensive patients were on diuretic treatment. The control of BP in patients on diuretics was not satisfactory, but there was no worsening of glycemic control compared to other antihypertensive therapy. This shows that low dose thiazides in combination with other antihypertensives can be safe in diabetic-hypertensive patients however their efficacy needs further scrutiny. DOI: http://dx.doi.org/10.3126/ajms.v6i2.10582 Asian Journal of Medical Sciences Vol.6(2) 2015 15-18
机译:背景:与非糖尿病患者相比,糖尿病患者中高血压更为常见。为了大幅减少大血管和微血管并发症的发生率,需要一种积极的方法来诊断和治疗糖尿病患者的高血压。利尿剂作为一线或二线药物在高血压治疗中的作用引起了激烈的争论,因此,我们研究了糖尿病高血压患者中利尿剂的使用及其对血压和血糖控制的影响。方法:这项横断面研究在三级教学医院进行了六个月。记录了患者的详细信息,例如年龄,性别,身高,体重,合并症,血压,eGFR以及糖尿病和高血压的病程以及为高血压患者开的药物。使用描述性统计数据分析数据。结果:共纳入336例平均年龄64.55±9.51岁的糖尿病高血压患者。四十五例患者使用利尿剂,其中两例(4.4%)使用利尿剂单药治疗,十六例(35.6%)使用两种药物组合(利尿剂+ ACEI或ARB),21例(46.7%)使用三种药物组合(利尿剂+ ARB和BBs)或利尿剂+ ACEI和BB或利尿剂+ ARB和CCB)和6种(13.3%)用于四种药物组合(利尿剂+ ARB,CCB和BB)。在利尿剂联合治疗的患者中,有23名患者(51%)的血压得到了良好控制,血糖控制与未使用利尿剂的患者相当。结论:本研究中利尿剂的使用与指南一致。约有13%的糖尿病高血压患者接受利尿剂治疗。利尿剂患者对BP的控制效果不理想,但与其他降压治疗相比,血糖控制没有恶化。这表明低剂量的噻嗪类药物与其他降压药合用在糖尿病-高血压患者中是安全的,但是其疗效尚需进一步研究。 DOI:http://dx.doi.org/10.3126/ajms.v6i2.10582亚洲医学杂志Vol.6(2)2015 15-18

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号